Fatty acid desaturase 2 (FADS2) is considered a key determinant of hepatic steatosis, as its increased expression raises polyunsaturated fatty acid levels and reduces de novo lipogenesis [411, 412]. This evidence concerns the gene FADS2 and fatty liver disease.